Harrow (HROW) Research & Development (2010 - 2026)

Harrow's (HROW) quarterly Research & Development came in at $5.9 million in Q1 2026, up 94.81% year-on-year from $3.0 million in Q1 2025, and down 49.71% quarter-over-quarter from $11.7 million in Q4 2025.

Harrow (HROW) Research & Development (2010 - 2026) Analysis & Trends

Harrow's Research & Development history runs 17 years deep, the most recent figure standing at $5.9 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 94.81% year-over-year to $5.9 million in Q1 2026; TTM through Mar 2026 was $23.8 million, a 81.65% increase from a year earlier, with the FY2025 full-year figure at $20.9 million, up 71.22% from the prior year.
  • Research & Development eased to $5.9 million in Q1 2026 per HROW's latest filing, from $11.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $11.7 million in Q4 2025 and bottomed at $658000.0 in Q1 2022.
  • The 5-year median for Research & Development is $2.3 million (2024), against an average of $2.9 million.
  • Across the five-year window, Research & Development tumbled 87.35% in 2022 and jumped 374.54% in 2023, its largest moves.
  • Year by year, Research & Development stood at $703000.0 in 2022, then surged by 374.54% to $3.3 million in 2023, then soared by 42.54% to $4.8 million in 2024, then soared by 146.54% to $11.7 million in 2025, then tumbled by 49.71% to $5.9 million in 2026.
  • Per Business Quant, the three latest HROW Research & Development figures stand at $5.9 million (Q1 2026), $11.7 million (Q4 2025), and $3.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 138.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 97.00 Mn
10 Harrow 1.43 Bn 1.34 Bn 27.05 Mn 5.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.90 Mn
Dec 31, 2025 11.72 Mn
Sep 30, 2025 3.32 Mn
Jun 30, 2025 2.87 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 4.76 Mn
Sep 30, 2024 2.27 Mn
Jun 30, 2024 3.05 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 3.34 Mn
Sep 30, 2023 1.42 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 734,000.00
Dec 31, 2022 703,000.00
Sep 30, 2022 775,000.00
Jun 30, 2022 914,000.00
Mar 31, 2022 658,000.00
Dec 31, 2021 3.94 Mn
Sep 30, 2021 6.13 Mn
Jun 30, 2021 425,000.00